Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin

By Kasparkova Jana   Fojta Miroslav   Farrell Nicholas  

Nucleic Acids Research, Vol. 32, Iss. 18, 2004-01 ,pp. : 5546-5552

Oxford University Press

Access to resources Recommend Favorite

Binding properties of an orally active platinum anti-tumor drug JM216 with metallothionein in vivo

By Xing B.  

BioMetals, Vol. 13, Iss. 3, 2000-09 ,pp. : 203-208

Springer Publishing Company

Access to resources Recommend Favorite

Coordination modes vs. antitumor activity: synthesis and antitumor activity of novel platinum(II) complexes of N-substituted amino dicarboxylic acids

By Kim Y.-S.   Song R.   Chung H.C.   Jun M.J.   Sohn Y.S.  

Journal of Inorganic Biochemistry, Vol. 98, Iss. 1, 2004-01 ,pp. : 98-104

Elsevier

Access to resources Recommend Favorite

Multinuclear NMR spectroscopy and antitumor activity of novel platinum(II) complexes with 5,7-disubstituted-1,2,4-triazolo[1,5-a]pyrimidines

By Lakomska I.   Szlyk E.   Sitkowski J.   Kozerski L.   Wietrzyk J.   Pelczynska M.   Nasulewicz A.   Opolski A.  

Journal of Inorganic Biochemistry, Vol. 98, Iss. 1, 2004-01 ,pp. : 167-172

Elsevier

Access to resources Recommend Favorite

Bis(aminoalcohol)dichloroplatinum(II) complexes and their mono and double ring-closed alcoholato species. Novel prodrugs for platinum based antitumor chemotherapy

By Arion V.B.   Galanski M.   Baumgartner C.   Meelich K.   Fremuth M.   Jakupec M.A.   Keppler B.K.  

Journal of Inorganic Biochemistry, Vol. 96, Iss. 1, 2003-07 ,pp. : 93-93

Elsevier

Access to resources Recommend Favorite